TG Therapeutics Inc (TGTX)
Current ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total current assets | US$ in thousands | 566,359 | 574,069 | 389,150 | 360,581 | 317,943 | 319,114 | 208,574 | 184,783 | 168,274 | 182,922 | 202,560 | 242,216 | 330,965 | 371,779 | 455,068 | 535,013 | 611,740 | 260,335 | 280,938 | 88,016 |
Total current liabilities | US$ in thousands | 90,679 | 125,114 | 108,664 | 99,684 | 53,720 | 57,678 | 72,667 | 63,076 | 53,201 | 36,447 | 43,326 | 54,656 | 65,384 | 87,655 | 87,551 | 92,494 | 87,554 | 77,670 | 67,537 | 63,118 |
Current ratio | 6.25 | 4.59 | 3.58 | 3.62 | 5.92 | 5.53 | 2.87 | 2.93 | 3.16 | 5.02 | 4.68 | 4.43 | 5.06 | 4.24 | 5.20 | 5.78 | 6.99 | 3.35 | 4.16 | 1.39 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $566,359K ÷ $90,679K
= 6.25
TG Therapeutics Inc's current ratio has fluctuated over the past few years, indicating changes in its short-term liquidity position.
As of December 31, 2024, the company's current ratio stands at 6.25, suggesting that it has $6.25 in current assets for every $1 in current liabilities, which reflects a strong liquidity position.
Looking at the trend, the ratio peaked at 6.99 on December 31, 2020, and has generally remained above 4 since then, with some fluctuations. However, in recent quarters, the current ratio has started to decline, reaching 3.58 on June 30, 2024.
While the current ratio is an important measure of a company's short-term financial health, it is essential to consider other financial ratios and factors to get a comprehensive understanding of TG Therapeutics Inc's overall financial performance and liquidity management.
Peer comparison
Dec 31, 2024